Frombach, J.; Rancan, F.; Kübrich, K.; Schumacher, F.; Unbehauen, M.; Blume-Peytavi, U.; Haag, R.; Kleuser, B.; Sabat, R.; Wolk, K.;
et al. Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers. Pharmaceutics 2020, 12, 862.
https://doi.org/10.3390/pharmaceutics12090862
AMA Style
Frombach J, Rancan F, Kübrich K, Schumacher F, Unbehauen M, Blume-Peytavi U, Haag R, Kleuser B, Sabat R, Wolk K,
et al. Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers. Pharmaceutics. 2020; 12(9):862.
https://doi.org/10.3390/pharmaceutics12090862
Chicago/Turabian Style
Frombach, Janna, Fiorenza Rancan, Katharina Kübrich, Fabian Schumacher, Michael Unbehauen, Ulrike Blume-Peytavi, Rainer Haag, Burkhard Kleuser, Robert Sabat, Kerstin Wolk,
and et al. 2020. "Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers" Pharmaceutics 12, no. 9: 862.
https://doi.org/10.3390/pharmaceutics12090862
APA Style
Frombach, J., Rancan, F., Kübrich, K., Schumacher, F., Unbehauen, M., Blume-Peytavi, U., Haag, R., Kleuser, B., Sabat, R., Wolk, K., & Vogt, A.
(2020). Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers. Pharmaceutics, 12(9), 862.
https://doi.org/10.3390/pharmaceutics12090862